How many institutions own PTIX stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own PTIX shares is 15, representing 7.39% of the company's common stock.

Who are the major shareholders selling Protagenic Therapeutics, Inc. stock?

CITADEL ADVISORS LLC, in the last quarter, reduced its stake in PTIX by -100% restricting it's holding to 0 shares of worth nearly -. SUSQUEHANNA INTERNATIONAL GROUP, LLP also lessened -100% of the PTIX shares from its portfolio, reducing its holding to 0 shares of worth -. HARBOR INVESTMENT ADVISORY, LLC also shunned PTIX shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying PTIX stock?

As per its latest 13F filing, BANK OF AMERICA CORP /DE/ increased its stake in PTIX by 100% in the last quarter. The institutional holder raised its holding to 4 shares having worth more than $2.00. SUSQUEHANNA INTERNATIONAL GROUP, LLP also added 100% more shares of PTIX to its portfolio, raising its holding to 13.98 thousand shares of worth $5.84K. CITADEL ADVISORS LLC also increased its PTIX shares holding by 45.58% which brought its holding to 23.48 thousand shares worth $9.82K.

PTIX's major insiders: who are they?

The insider with the most stakes in PTIX is Trinad Capital Master Fund Ltd. , 10 percent owner at the company. Additionally, PTIX stock is highly held by director KIER ISAAC and Exec VP, Corporate Development MUSCI RAYMOND among others.

Did an insider recently sell PTIX stock?

Company executives, directors, and other insiders own 3.84% percent of Protagenic Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which PTIX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include WALKER SCOTT, BANON SID, and CHAZEN JEROME A.

Which insider recently purchased PTIX stock?

There have been 0 transaction(s) during the past 6-months in which Protagenic Therapeutics, Inc. insiders have bought stock, totalling 0 shares

How much of PTIX does insiders own?

Around 0 Protagenic Therapeutics, Inc. shares are held by insiders, which represents about 3.84% of PTIX stock.

Who is the insider with the largest stake?

PTIX 10 percent owner, Trinad Capital Master Fund Ltd. holds the largest portfolio of the company's shares. PTIX shares owned by Trinad total nearly 3.12 million.

Which institution holds the most shares in PTIX?

CITADEL ADVISORS LLC is the largest institutional owner in PTIX which holds 0 shares worth - or 0% of the total PTIX shares outstanding followed by SUSQUEHANNA INTERNATIONAL GROUP, LLP with ownership of 0 shares representing 0% of the PTIX ownership. HARBOR INVESTMENT ADVISORY, LLC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Is Protagenic Therapeutics, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the PTIX is concerned, it is a stock which is not optionable.

Is there a short position on PTIX's shares?

Number of PTIX shares short is 44.93K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding PTIX shares are there?

As of today, 868.41K shares of PTIX are outstanding.

Is there many float in PTIX stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, PTIX has 491.61K shares in float.

PTIX short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for PTIX is 0.01.

Protagenic Therapeutics (PTIX) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares5.17

Short Percent Of Float5.61

Shares Outstanding868.41K

Shares Float491.61K

Shares Short44.93K

Short Ratio0.01

5.61%

Short % of Float

5.17%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

3.84% Percentage of Shares held by All Insiders

7.39% Percentage of Shares held by All Institutions

7.68% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 7.39% of PTIX shares are held by financial institutions. CITADEL ADVISORS LLC is the top corporate investor, holding 0 shares valued at -. A 0% stake in Protagenic Therapeutics, Inc. is owned by the company. SUSQUEHANNA INTERNATIONAL GROUP, LLP owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2023	CITADEL ADVISORS LLC	0%	0	-	-23.48K	-100.00%
Mar 31, 2023	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0%	0	-	-13.98K	-100.00%
Mar 31, 2023	HARBOR INVESTMENT ADVISORY, LLC	0%	0	-	-1	-100.00%
Mar 31, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-6.21K	-100.00%
Mar 31, 2023	CWM, LLC	0%	0	-	-3	-100.00%
Mar 31, 2023	BANK OF AMERICA CORP /DE/	0%	0	-	-4	-100.00%
Mar 31, 2023	WELLS FARGO & COMPANY/MN	0%	0	-	-90	-100.00%
Mar 31, 2023	NORTHERN TRUST CORP	0%	0	-	-22.49K	-100.00%
Mar 31, 2023	STATE STREET CORP	0%	0	-	-55.25K	-100.00%
Mar 31, 2023	VANGUARD GROUP INC	0%	0	-	-236.31K	-100.00%
Mar 31, 2023	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	0%	0	-	0	0
Mar 31, 2023	MORGAN STANLEY	0%	0	-	-1	-100.00%
Mar 31, 2023	GEODE CAPITAL MANAGEMENT, LLC	0%	0	-	-103.6K	-100.00%
Mar 31, 2023	VIRTU FINANCIAL LLC	0%	0	-	-10.11K	-100.00%
Mar 31, 2023	WARBERG ASSET MANAGEMENT LLC	0%	0	-	-20K	-100.00%
Mar 31, 2023	UBS GROUP AG	0%	0	-	-17.15K	-100.00%
Mar 31, 2023	CONCORDE ASSET MANAGEMENT, LLC	0%	0	-	-16.72K	-100.00%
Mar 31, 2023	ADVISOR GROUP HOLDINGS, INC.	0%	0	-	-11.06K	-100.00%
Mar 31, 2023	FNY INVESTMENT ADVISERS, LLC	0%	0	-	-75K	-100.00%
Dec 31, 2022	BANK OF AMERICA CORP /DE/	0%	4	2	4	+100.00%
Dec 31, 2022	RENAISSANCE TECHNOLOGIES LLC	0%	0	-	-21.03K	-100.00%
Dec 31, 2022	MORGAN STANLEY	0%	1	-	-1	-50.00%
Dec 31, 2022	VANGUARD GROUP INC	5.47%	236.31K	94.52K	-16.52K	-6.53%
Dec 31, 2022	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.32%	13.98K	5.84K	13.98K	+100.00%
Dec 31, 2022	GEODE CAPITAL MANAGEMENT, LLC	2.4%	103.6K	43K	-284	-0.27%
Dec 31, 2022	FNY INVESTMENT ADVISERS, LLC	1.74%	75K	31K	0	0
Dec 31, 2022	STATE STREET CORP	1.28%	55.25K	23.09K	0	0
Dec 31, 2022	CITADEL ADVISORS LLC	0.54%	23.48K	9.82K	7.35K	+45.58%
Dec 31, 2022	NORTHERN TRUST CORP	0.52%	22.49K	8.99K	0	0
Dec 31, 2022	WARBERG ASSET MANAGEMENT LLC	0.46%	20K	8K	20K	+100.00%
Dec 31, 2022	CONCORDE ASSET MANAGEMENT, LLC	0.39%	16.72K	6.69K	0	0
Dec 31, 2022	ADVISOR GROUP HOLDINGS, INC.	0.26%	11.06K	4K	0	0
Dec 31, 2022	VIRTU FINANCIAL LLC	0.23%	10.11K	4K	-470	-4.44%
Dec 31, 2022	TOWER RESEARCH CAPITAL LLC (TRC)	0.14%	6.21K	2K	-321	-4.92%
Dec 31, 2022	WELLS FARGO & COMPANY/MN	0%	90	36	90	+100.00%
Dec 31, 2022	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	0%	0	-	0	0
Dec 31, 2022	UBS GROUP AG	0.4%	17.15K	6.86K	10.68K	+164.83%
Dec 31, 2022	CWM, LLC	0%	3	-	0	0
Dec 31, 2022	HARBOR INVESTMENT ADVISORY, LLC	0%	1	-	0	0

Insiders

Among the PTIX insiders holding of 3.84% of the stake in company, TRINAD CAPITAL MASTER FUND LTD., 10 percent owner, holds the largest shares of 3.12M. KIER ISAAC, director, is the second largest PTIX insider with ownership of 1.79M shares. MUSCI RAYMOND, Exec VP, Corporate Development, stands third with possession of 445.89K shares of that stake.

Insiders	Designation	Shares Held
TRINAD CAPITAL MASTER FUND LTD.	10 percent owner	3.12M
KIER ISAAC	director	1.79M
MUSCI RAYMOND	Exec VP, Corporate Development	445.89K
BRILLIANT DIGITAL ENTERTAINMENT INC	10 percent owner	360.35K
CHAZEN JEROME A	director	238.01K
WALKER SCOTT	Chief Marketing Officer	108.04K
BANON SID		59.5K
ARROW ALEXANDER K.	Chief Financial Officer	45.82K
ARMEN GARO H	Executive Chairman	0
BARRAGE KHALIL	director	0

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Oct 12, 2023	ARROW ALEXANDER K.	PURCHASE	0.81	8K	6.48K	45.82K
May 17, 2022	ARROW ALEXANDER K.	PURCHASE	0.71	23K	16.33K	143.26K
Jun 03, 2021	ARROW ALEXANDER K.	PURCHASE	4.98	16.9K	84.16K	50K
Jun 02, 2021	ARROW ALEXANDER K.	PURCHASE	4.98	100	498	33.1K
May 27, 2021	ARROW ALEXANDER K.	PURCHASE	4.98	3K	14.94K	33K
May 18, 2021	ARROW ALEXANDER K.	PURCHASE	4.98	12K	59.76K	12K
Apr 30, 2021	ARROW ALEXANDER K.	PURCHASE	2.29	1K	2.29K	120.26K
Apr 29, 2021	ARROW ALEXANDER K.	PURCHASE	2.29	1K	2.29K	119.26K
Nov 20, 2019	ARMEN GARO H	PURCHASE	1.25	0	-	0
Nov 05, 2019	BARRAGE KHALIL	PURCHASE	1.25	0	-	0
Jun 17, 2016	ARMEN GARO H	PURCHASE	1.25	60.21K	75.26K	4.3M
Apr 15, 2016	ARROW ALEXANDER K.	PURCHASE	1.25	40K	50K	100K
May 31, 2011	BRILLIANT DIGITAL ENTERTAINMENT INC	PURCHASE	2.97	360.35K	1.07M	360.35K
Dec 13, 2010	MUSCI RAYMOND	PURCHASE	1.97	266	524.02	445.89K
Dec 10, 2010	MUSCI RAYMOND	PURCHASE	1.59	200	318	436.02K
Dec 21, 2009	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	0.60	5.38K	3.23K	3.12M
Dec 14, 2009	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	0.65	527.68K	342.89K	3.11M
Dec 09, 2009	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	0.67	21.95K	14.7K	2.58M
Dec 08, 2009	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	0.66	86.39K	56.99K	2.56M
Nov 19, 2009	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	0.85	25K	21.25K	2.47M
Nov 16, 2009	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	0.85	50.5K	42.93K	2.45M
Nov 13, 2009	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	0.86	50K	42.92K	2.4M
Nov 12, 2009	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	0.85	11.1K	9.44K	2.35M
Nov 25, 2008	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	1.17	25K	29.29K	2.34M
Aug 29, 2008	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	4.03	25K	100.66K	2.31M
Jun 13, 2008	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	4.30	10K	42.97K	2.29M
Jun 11, 2008	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	4.36	10K	43.6K	2.28M
Jun 10, 2008	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	4.31	10K	43.11K	2.27M
Jun 05, 2008	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	4.21	10K	42.07K	2.26M
Jun 02, 2008	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	4.00	35K	140K	2.25M
May 30, 2008	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	4.56	35K	159.75K	2.21M
Nov 30, 2007	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	14.00	12.5K	175K	1.5M
Mar 08, 2007	WALKER SCOTT	SALE	0.00	53.54K	-	108.04K
Feb 12, 2007	TRINAD CAPITAL MASTER FUND LTD.	PURCHASE	0.01	360M	3.49M	429.75M
Oct 24, 2006	BANON SID	SALE	0.02	586.22K	11.72K	59.5K
Oct 24, 2006	CHAZEN JEROME A	SALE	0.02	2.34M	46.9K	238.01K
Oct 24, 2006	KIER ISAAC	SALE	0.02	17.59M	351.73K	1.79M

PTIX Stock Ownership Breakdown